CMPX

NASD Compass Therapeutics, Inc.
Nov 19, 2026 · 9:10 PM ET EOD Market Closed

$0.6785 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.6785, $0.0057 below the day’s high of $0.6842

YTD change
-87.36%
vs 20-day SMA
-9.92%
vs 200-day SMA
-76.11%

Price ranges

Previous day
$0.5935 $0.6400
open $0.6238 close $0.6110
-$0.0128 (-2.05%)
Today
$0.6042 $0.6842
open $0.6178 now $0.6785
+$0.0607 (+9.83%)
Past week
$0.5700 $0.8302
from $0.8302 now $0.6785
-$0.1517 (-18.27%)
Past month
$0.5700 $0.8958
from $0.8145 now $0.6785
-$0.1360 (-16.70%)
This year
$0.5700 $6.8800
from $5.3700 now $0.6785
-$4.6915 (-87.36%)

Price & Performance

-1.13 (-62.51%) / 6M

$0.4528$1.20$1.94$2.68May 19Aug 20Nov 19

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 92.5% away from all-time highs of $9.0000
  • CMPX is down 87% since the beginning of the year
  • CMPX is down 86% over the past 12 months
  • CMPX is down 17% over the past 1 month
  • 29% of all CMPX investors are betting against CMPX

CMPX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -86.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.15
Earnings momentum -1.7% Quarterly EPS growth
Quarterly change -1.7%

Valuation

P/E ratio N/A
Enterprise value $-39690400.0
Beta 1.44

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$163.1M
Debt$9.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $122.2M

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.82 -1.14%
MRNA Moderna, Inc. $199.33 +1.29%
RVMD Revolution Medicines, Inc. $159.43 -0.24%
ROIV Roivant Sciences Ltd. $38.96 +0.59%
BNTX BioNTech SE Sponsored ADR $81.38 -2.26%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.